Report Detail

Request for Sample of this report

Chemical & Material Global Filgotinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4512633
    • |
  • 16 February, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
According to our (Global Info Research) latest study, the global Filgotinib market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Filgotinib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Filgotinib market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Filgotinib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Filgotinib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (K USD/Kg), 2018-2029
Global Filgotinib market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (K USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Filgotinib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Filgotinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cayman Chemical, BioVision, Adooq Bioscience, Taiclone and Clearsynth, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Filgotinib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Market segment by Application
Research
Medical
Major players covered
Cayman Chemical
BioVision
Adooq Bioscience
Taiclone
Clearsynth
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
J&K Scientific
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Filgotinib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Filgotinib, with price, sales, revenue and global market share of Filgotinib from 2018 to 2023.
Chapter 3, the Filgotinib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Filgotinib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Filgotinib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Filgotinib.
Chapter 14 and 15, to describe Filgotinib sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Filgotinib
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Filgotinib Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Min Purity Less Than 98%
    • 1.3.3 Min Purity 98%-99%
    • 1.3.4 Min Purity More Than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Filgotinib Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research
    • 1.4.3 Medical
  • 1.5 Global Filgotinib Market Size & Forecast
    • 1.5.1 Global Filgotinib Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Filgotinib Sales Quantity (2018-2029)
    • 1.5.3 Global Filgotinib Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Cayman Chemical
    • 2.1.1 Cayman Chemical Details
    • 2.1.2 Cayman Chemical Major Business
    • 2.1.3 Cayman Chemical Filgotinib Product and Services
    • 2.1.4 Cayman Chemical Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Cayman Chemical Recent Developments/Updates
  • 2.2 BioVision
    • 2.2.1 BioVision Details
    • 2.2.2 BioVision Major Business
    • 2.2.3 BioVision Filgotinib Product and Services
    • 2.2.4 BioVision Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BioVision Recent Developments/Updates
  • 2.3 Adooq Bioscience
    • 2.3.1 Adooq Bioscience Details
    • 2.3.2 Adooq Bioscience Major Business
    • 2.3.3 Adooq Bioscience Filgotinib Product and Services
    • 2.3.4 Adooq Bioscience Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Adooq Bioscience Recent Developments/Updates
  • 2.4 Taiclone
    • 2.4.1 Taiclone Details
    • 2.4.2 Taiclone Major Business
    • 2.4.3 Taiclone Filgotinib Product and Services
    • 2.4.4 Taiclone Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Taiclone Recent Developments/Updates
  • 2.5 Clearsynth
    • 2.5.1 Clearsynth Details
    • 2.5.2 Clearsynth Major Business
    • 2.5.3 Clearsynth Filgotinib Product and Services
    • 2.5.4 Clearsynth Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Clearsynth Recent Developments/Updates
  • 2.6 Biorbyt
    • 2.6.1 Biorbyt Details
    • 2.6.2 Biorbyt Major Business
    • 2.6.3 Biorbyt Filgotinib Product and Services
    • 2.6.4 Biorbyt Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Biorbyt Recent Developments/Updates
  • 2.7 APExBIO Technology
    • 2.7.1 APExBIO Technology Details
    • 2.7.2 APExBIO Technology Major Business
    • 2.7.3 APExBIO Technology Filgotinib Product and Services
    • 2.7.4 APExBIO Technology Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 APExBIO Technology Recent Developments/Updates
  • 2.8 Selleck Chemicals
    • 2.8.1 Selleck Chemicals Details
    • 2.8.2 Selleck Chemicals Major Business
    • 2.8.3 Selleck Chemicals Filgotinib Product and Services
    • 2.8.4 Selleck Chemicals Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Selleck Chemicals Recent Developments/Updates
  • 2.9 AbMole
    • 2.9.1 AbMole Details
    • 2.9.2 AbMole Major Business
    • 2.9.3 AbMole Filgotinib Product and Services
    • 2.9.4 AbMole Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 AbMole Recent Developments/Updates
  • 2.10 BOC Sciences
    • 2.10.1 BOC Sciences Details
    • 2.10.2 BOC Sciences Major Business
    • 2.10.3 BOC Sciences Filgotinib Product and Services
    • 2.10.4 BOC Sciences Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 BOC Sciences Recent Developments/Updates
  • 2.11 TargetMol
    • 2.11.1 TargetMol Details
    • 2.11.2 TargetMol Major Business
    • 2.11.3 TargetMol Filgotinib Product and Services
    • 2.11.4 TargetMol Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 TargetMol Recent Developments/Updates
  • 2.12 Toronto Research Chemicals
    • 2.12.1 Toronto Research Chemicals Details
    • 2.12.2 Toronto Research Chemicals Major Business
    • 2.12.3 Toronto Research Chemicals Filgotinib Product and Services
    • 2.12.4 Toronto Research Chemicals Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Toronto Research Chemicals Recent Developments/Updates
  • 2.13 J&K Scientific
    • 2.13.1 J&K Scientific Details
    • 2.13.2 J&K Scientific Major Business
    • 2.13.3 J&K Scientific Filgotinib Product and Services
    • 2.13.4 J&K Scientific Filgotinib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 J&K Scientific Recent Developments/Updates

3 Competitive Environment: Filgotinib by Manufacturer

  • 3.1 Global Filgotinib Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Filgotinib Revenue by Manufacturer (2018-2023)
  • 3.3 Global Filgotinib Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Filgotinib by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Filgotinib Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Filgotinib Manufacturer Market Share in 2022
  • 3.5 Filgotinib Market: Overall Company Footprint Analysis
    • 3.5.1 Filgotinib Market: Region Footprint
    • 3.5.2 Filgotinib Market: Company Product Type Footprint
    • 3.5.3 Filgotinib Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Filgotinib Market Size by Region
    • 4.1.1 Global Filgotinib Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Filgotinib Consumption Value by Region (2018-2029)
    • 4.1.3 Global Filgotinib Average Price by Region (2018-2029)
  • 4.2 North America Filgotinib Consumption Value (2018-2029)
  • 4.3 Europe Filgotinib Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Filgotinib Consumption Value (2018-2029)
  • 4.5 South America Filgotinib Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Filgotinib Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Filgotinib Sales Quantity by Type (2018-2029)
  • 5.2 Global Filgotinib Consumption Value by Type (2018-2029)
  • 5.3 Global Filgotinib Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Filgotinib Sales Quantity by Application (2018-2029)
  • 6.2 Global Filgotinib Consumption Value by Application (2018-2029)
  • 6.3 Global Filgotinib Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Filgotinib Sales Quantity by Type (2018-2029)
  • 7.2 North America Filgotinib Sales Quantity by Application (2018-2029)
  • 7.3 North America Filgotinib Market Size by Country
    • 7.3.1 North America Filgotinib Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Filgotinib Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Filgotinib Sales Quantity by Type (2018-2029)
  • 8.2 Europe Filgotinib Sales Quantity by Application (2018-2029)
  • 8.3 Europe Filgotinib Market Size by Country
    • 8.3.1 Europe Filgotinib Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Filgotinib Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Filgotinib Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Filgotinib Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Filgotinib Market Size by Region
    • 9.3.1 Asia-Pacific Filgotinib Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Filgotinib Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Filgotinib Sales Quantity by Type (2018-2029)
  • 10.2 South America Filgotinib Sales Quantity by Application (2018-2029)
  • 10.3 South America Filgotinib Market Size by Country
    • 10.3.1 South America Filgotinib Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Filgotinib Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Filgotinib Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Filgotinib Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Filgotinib Market Size by Country
    • 11.3.1 Middle East & Africa Filgotinib Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Filgotinib Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Filgotinib Market Drivers
  • 12.2 Filgotinib Market Restraints
  • 12.3 Filgotinib Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Filgotinib and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Filgotinib
  • 13.3 Filgotinib Production Process
  • 13.4 Filgotinib Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Filgotinib Typical Distributors
  • 14.3 Filgotinib Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Filgotinib. Industry analysis & Market Report on Filgotinib is a syndicated market report, published as Global Filgotinib Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Filgotinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,208.56
    		4,812.84
    		6,417.12
    		547,021.20
    		820,531.80
    		1,094,042.40
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo